2025 annual financial data
Vertex Pharmaceuticals 2025 Operating margin
Vertex Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 39.43%.
Operating income was 4,760,700,000 USD and net income was 3,953,200,000 USD.
Operating cash flow was 3,631,400,000 USD.
Verified data
- Revenue
- 12,074,600,000 USD
- Operating income
- 4,760,700,000 USD
- Net income
- 3,953,200,000 USD
- Operating cash flow
- 3,631,400,000 USD